High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

Manuela Gambella, Alberto Rocci, Roberto Passera, Francesca Gay, Paola Omedè, Claudia Crippa, Paolo Corradini, Alessandra Romano, Davide Rossi, Marco Ladetto, Mario Boccadoro, Antonio Palumbo

Research output: Contribution to journal › Article

22 Citations (Scopus)
Original languageEnglish
JournalHaematologica
Volume99
Issue number2
DOIs
Publication statusPublished - Feb 1 2014

Keywords

  • BLIMP1
  • Bortezomib
  • IRF4
  • Multiple myeloma biomarker
  • XBP1

ASJC Scopus subject areas

  • Hematology

Cite this

Gambella, M., Rocci, A., Passera, R., Gay, F., Omedè, P., Crippa, C., ... Palumbo, A. (2014). High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. Haematologica, 99(2). https://doi.org/10.3324/haematol.2013.090142

High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. / Gambella, Manuela; Rocci, Alberto; Passera, Roberto; Gay, Francesca; Omedè, Paola; Crippa, Claudia; Corradini, Paolo; Romano, Alessandra; Rossi, Davide; Ladetto, Marco; Boccadoro, Mario; Palumbo, Antonio.

In: Haematologica, Vol. 99, No. 2, 01.02.2014.

Research output: Contribution to journal › Article

Gambella, M, Rocci, A, Passera, R, Gay, F, Omedè, P, Crippa, C, Corradini, P, Romano, A, Rossi, D, Ladetto, M, Boccadoro, M & Palumbo, A 2014, 'High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib', Haematologica, vol. 99, no. 2. https://doi.org/10.3324/haematol.2013.090142
Gambella M, Rocci A, Passera R, Gay F, Omedè P, Crippa C et al. High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. Haematologica. 2014 Feb 1;99(2). https://doi.org/10.3324/haematol.2013.090142
Gambella, Manuela ; Rocci, Alberto ; Passera, Roberto ; Gay, Francesca ; Omedè, Paola ; Crippa, Claudia ; Corradini, Paolo ; Romano, Alessandra ; Rossi, Davide ; Ladetto, Marco ; Boccadoro, Mario ; Palumbo, Antonio. / High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib. In: Haematologica. 2014 ; Vol. 99, No. 2.
@article{53e3a325d0a94234bacc983c05b8bdd5,
title = "High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib",
keywords = "BLIMP1, Bortezomib, IRF4, Multiple myeloma biomarker, XBP1",
author = "Manuela Gambella and Alberto Rocci and Roberto Passera and Francesca Gay and Paola Omed{\`e} and Claudia Crippa and Paolo Corradini and Alessandra Romano and Davide Rossi and Marco Ladetto and Mario Boccadoro and Antonio Palumbo",
year = "2014",
month = "2",
day = "1",
doi = "10.3324/haematol.2013.090142",
language = "English",
volume = "99",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - High XBP1 expression is a marker of better outcome in multiple myeloma patients treated with bortezomib

AU - Gambella, Manuela

AU - Rocci, Alberto

AU - Passera, Roberto

AU - Gay, Francesca

AU - Omedè, Paola

AU - Crippa, Claudia

AU - Corradini, Paolo

AU - Romano, Alessandra

AU - Rossi, Davide

AU - Ladetto, Marco

AU - Boccadoro, Mario

AU - Palumbo, Antonio

PY - 2014/2/1

Y1 - 2014/2/1

KW - BLIMP1

KW - Bortezomib

KW - IRF4

KW - Multiple myeloma biomarker

KW - XBP1

UR - http://www.scopus.com/inward/record.url?scp=84896736185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896736185&partnerID=8YFLogxK

U2 - 10.3324/haematol.2013.090142

DO - 10.3324/haematol.2013.090142

M3 - Article

C2 - 24497562

AN - SCOPUS:84896736185

VL - 99

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -

Access to Document